142 related articles for article (PubMed ID: 38577694)
1. Post-therapeutic squamous cell transformation of a metastatic prostate adenocarcinoma with comparison of molecular profiles: a case report and review of the literature.
Li P; Haines GK; Si Q; Baskovich B
Int J Clin Exp Pathol; 2024; 17(3):78-82. PubMed ID: 38577694
[TBL] [Abstract][Full Text] [Related]
2. Oligometastatic Squamous Cell Transformation From Metastatic Prostate Adenocarcinoma Treated With Systemic and Focal Therapy: A Case Report.
Autio K; McBride S
J Immunother Precis Oncol; 2022 Aug; 5(3):79-83. PubMed ID: 36034583
[TBL] [Abstract][Full Text] [Related]
3. Metastatic squamous cell carcinoma transformed from prostatic adenocarcinoma following androgen deprivation therapy: A case report with clinicopathologic and molecular findings.
Lau HD; Clark M
Diagn Cytopathol; 2020 Dec; 48(12):E14-E17. PubMed ID: 32628337
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of primary large cell neuroendocrine carcinoma of the prostate.
Nguyen N; Franz RD; Mohammed O; Huynh R; Son CK; Khan RN; Ahmed B
Front Oncol; 2024; 14():1341794. PubMed ID: 38515575
[TBL] [Abstract][Full Text] [Related]
5. TMPRSS2-ERG fusions unexpectedly identified in men initially diagnosed with nonprostatic malignancies.
Lara PN; Heilmann AM; Elvin JA; Parikh M; de Vere White R; Gandour-Edwards R; Evans CP; Pan CX; Schrock AB; Erlich R; Ross JS; Stephens PJ; McPherson J; Miller VA; Ali SM
JCO Precis Oncol; 2017; 2017():. PubMed ID: 29629426
[TBL] [Abstract][Full Text] [Related]
6. Primary Adenosquamous Carcinoma of the Prostate.
Demianets R; Ren D; Houshyar R; Giannico GA; Johnson C
Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38535065
[TBL] [Abstract][Full Text] [Related]
7. Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma.
Murray SK; Breau RH; Guha AK; Gupta R
Am J Surg Pathol; 2004 Sep; 28(9):1154-62. PubMed ID: 15316314
[TBL] [Abstract][Full Text] [Related]
8. Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma.
Han B; Mehra R; Suleman K; Tomlins SA; Wang L; Singhal N; Linetzky KA; Palanisamy N; Zhou M; Chinnaiyan AM; Shah RB
Mod Pathol; 2009 Sep; 22(9):1176-85. PubMed ID: 19465903
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma of the prostate following treatment with an LHRH-agonist: a rare case of transformation of adenocarcinoma of the prostate.
Al-Qassim Z; Mohammed A; Payne D; Stocks PJ; Khan Z
Cent European J Urol; 2014; 67(1):26-8. PubMed ID: 24982776
[TBL] [Abstract][Full Text] [Related]
10. Genomic analysis of circulating tumor cells in adenosquamous carcinoma of the prostate: a case report.
Kitamura J; Taguchi S; Okegawa T; Honda K; Kii T; Tomida Y; Matsumoto R; Ninomiya N; Masuda K; Nakamura Y; Yamaguchi T; Kinjo M; Tambo M; Isomura A; Hayashi A; Kamma H; Higashihara E; Shibahara J; Fukuhara H
BMC Med Genomics; 2021 Sep; 14(1):217. PubMed ID: 34479548
[TBL] [Abstract][Full Text] [Related]
11. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
Epstein JI; Egevad L; Humphrey PA; Montironi R;
Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features of metastatic small cell carcinoma of the prostate to the liver: a series of four cases.
Bell PD; Huber AR; Agostini-Vulaj D
Diagn Pathol; 2021 Apr; 16(1):35. PubMed ID: 33892760
[TBL] [Abstract][Full Text] [Related]
13. Brain metastasis in a patient with BRCA2-mutated treatment-related neuroendocrine prostate carcinoma and long-term response to radiotherapy and Olaparib: A case report and literature review.
Uehara R; Obinata D; Hashimoto S; Nakahara K; Uchida H; Yoshizawa T; Mochida J; Yamaguchi K; Sakaguchi M; Ozawa Y; Mori F; Miura K; Ishige T; Masuda S; Nakayama T; Takahashi S
Medicine (Baltimore); 2024 Mar; 103(9):e37371. PubMed ID: 38428891
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Performance of different prostate specific antibodies in the cytological diagnosis of metastatic prostate adenocarcinoma.
Jia L; Jiang Y; Michael CW
Diagn Cytopathol; 2017 Nov; 45(11):998-1004. PubMed ID: 28888085
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment.
Kadakia KC; Tomlins SA; Sanghvi SK; Cani AK; Omata K; Hovelson DH; Liu CJ; Cooney KA
J Hematol Oncol; 2015 Oct; 8():109. PubMed ID: 26444865
[TBL] [Abstract][Full Text] [Related]
17. NKX3.1 as a marker of prostatic origin in metastatic tumors.
Gurel B; Ali TZ; Montgomery EA; Begum S; Hicks J; Goggins M; Eberhart CG; Clark DP; Bieberich CJ; Epstein JI; De Marzo AM
Am J Surg Pathol; 2010 Aug; 34(8):1097-105. PubMed ID: 20588175
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of neuroendocrine prostate cancer.
Conteduca V; Oromendia C; Eng KW; Bareja R; Sigouros M; Molina A; Faltas BM; Sboner A; Mosquera JM; Elemento O; Nanus DM; Tagawa ST; Ballman KV; Beltran H
Eur J Cancer; 2019 Nov; 121():7-18. PubMed ID: 31525487
[TBL] [Abstract][Full Text] [Related]
19. [TMPRSS2-ERG gene fusion in metastatic prostate cancers: a study of fine needle aspiration specimens].
Xiao L; Zhu XZ; Wang Y; Gong Y; Guo CC
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):392-6. PubMed ID: 21914348
[TBL] [Abstract][Full Text] [Related]
20. Complete remission in a patient with metastatic mixed adenocarcinoma/extrapulmonary small cell carcinoma of the prostate.
Brammer JE; Lulla P; Lynch GR
Int J Clin Oncol; 2011 Dec; 16(6):722-5. PubMed ID: 21347630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
